Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$2.41 - $3.24 $38,314 - $51,509
-15,898 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$3.02 - $4.13 $356,970 - $488,174
-118,202 Reduced 88.14%
15,898 $50,000
Q3 2021

Nov 15, 2021

SELL
$2.98 - $3.48 $2,682 - $3,132
-900 Reduced 0.67%
134,100 $416,000
Q2 2021

Aug 12, 2021

BUY
$3.01 - $3.78 $406,350 - $510,300
135,000 New
135,000 $444,000

Others Institutions Holding VNRX

About VOLITIONRX LTD


  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $36.1M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.